Linked in Auditing Post-July16
•Download as DOCX, PDF•
0 likes•21 views
The document discusses the experience and qualifications of an individual offering auditing services for the pharmaceutical and veterinary industries in Australia and Asia. Specifically, they have over 40 years of experience in the pharmaceutical industry, have been a consultant for 27 years, and have been an approved APVMA auditor for 20 years. They are interested in finding more auditing work and have experience auditing various facilities including manufacturers, printers, laboratories, and more. Interested parties can contact them by phone to discuss opportunities.
Report
Share
Report
Share
Recommended
Rationale for the reporting and control of degradation
Rationale for the reporting and control of degradation, Reporting procedure, Identification of degradation products, Threshold for degradation products in new drug products, Analytical procedure, Reporting degradation products contents of batches.
UK Facilities
This document outlines various pharmaceutical manufacturing and production activities including non-GMP API manufacture and stability testing in UK facilities, GMP API manufacture, pharmaceutical development, clinical packaging and labeling, radio labeling, diagnostics, stores and distribution, ceph manufacture and packaging, and penicillin manufacture and packaging.
Pharmaceuticals industry
Pharmaceutical industry is a very vital segment of the
our health care system, which deals with manufacturing
and marketing of pharmaceuticals and biological
products and medicinal devices, used for the diagnosis
and treatment of diseases as well as conducts research
for development of new products for human welfare
TQM involves
building quality in a pharmaceutical product as it
involve complete records such as standard operating
procedures for every step, validation records, master
formula records and batch production records etc.
Gayatree dra
This document summarizes a presentation about the World Health Organization (WHO) Certification Scheme for pharmaceutical products moving in international trade. The presentation discusses the introduction and history of the scheme, its objectives to assure drug quality and safety, eligibility requirements for participation, and the types of certificates issued. It also describes how certificates are issued and the advantages of the scheme in standardizing information exchange between countries.
Therapeutics goods administration & Row Countries
The document discusses regulatory requirements for pharmaceutical products in Australia and other countries collectively referred to as the "Rest of the World" or ROW. It outlines the role of the Therapeutic Goods Administration (TGA) in Australia to ensure quality, safety and efficacy of medicines. The TGA approves higher risk medicines and includes lower risk listed medicines in the Australian Register of Therapeutic Goods. Manufacturers must be licensed and comply with Good Manufacturing Practice standards. ROW countries have similar regulatory frameworks with a focus on pre-market assessment, post-market monitoring, and licensing of manufacturers. Requirements for registration in various ROW regions are also summarized.
Assignment avd@ gmp
1) GMP (Good Manufacturing Practice) guidelines are important regulations that help ensure animal vaccines and other drugs/medical products are produced safely and are effective. They cover all aspects of production from materials to equipment to staff training.
2) Key components of GMP include quality management, quality control, sanitation, validation, documentation and more. Strict adherence to GMP helps reduce risks like contamination and errors that could harm patients.
3) For animal vaccines specifically, following GMP is critical given the live organisms involved and safety precautions needed. Facilities must be designed to properly handle biosafety requirements as well as aseptic processing.
Pharmacy “it’s even more than you can imagine.”
It help for students Doctor of Pharmacy (Pharm D), M Pharm -Pharmacy Practice, Bachelor of Pharmacy ,Diploma pharmacy, working pharmacist i.e community, hospital and clinical pharmacist - Scope of pharmacy and skills required to be success in pharmacy practice. It is produced and presented as a part of a part of " SKILL DEVELOPMENT TRAINING PROGRAM-2015" on 17 06 2015 as a part of Technical Session -II sponsored by Tirumala Tirupati Devasthanams Tirupati to the students of Sri Padmavathi Polytechnic Tirupati to bring a Co-Ordination between education and employability potentials in corporate sector.
GMB NEW (2).pptx
cGMP refers to current good manufacturing practices regulations enforced by the US FDA to ensure quality control of pharmaceutical products. cGMP provides minimum requirements for facilities, equipment, personnel, documentation, packaging and labeling. Some key points of cGMP include employing up-to-date technologies to prevent contamination and errors, following written standard operating procedures, conducting self-inspections, and ensuring raw materials, manufacturing processes and finished products meet specifications. Strict adherence to cGMP is important as it helps ensure the safety, efficacy and consistency of pharmaceutical products for patients. Incidents like the thalidomide tragedy and Tylenol tampering case demonstrate why following cGMP is crucial in the pharmaceutical industry.
Recommended
Rationale for the reporting and control of degradation
Rationale for the reporting and control of degradation, Reporting procedure, Identification of degradation products, Threshold for degradation products in new drug products, Analytical procedure, Reporting degradation products contents of batches.
UK Facilities
This document outlines various pharmaceutical manufacturing and production activities including non-GMP API manufacture and stability testing in UK facilities, GMP API manufacture, pharmaceutical development, clinical packaging and labeling, radio labeling, diagnostics, stores and distribution, ceph manufacture and packaging, and penicillin manufacture and packaging.
Pharmaceuticals industry
Pharmaceutical industry is a very vital segment of the
our health care system, which deals with manufacturing
and marketing of pharmaceuticals and biological
products and medicinal devices, used for the diagnosis
and treatment of diseases as well as conducts research
for development of new products for human welfare
TQM involves
building quality in a pharmaceutical product as it
involve complete records such as standard operating
procedures for every step, validation records, master
formula records and batch production records etc.
Gayatree dra
This document summarizes a presentation about the World Health Organization (WHO) Certification Scheme for pharmaceutical products moving in international trade. The presentation discusses the introduction and history of the scheme, its objectives to assure drug quality and safety, eligibility requirements for participation, and the types of certificates issued. It also describes how certificates are issued and the advantages of the scheme in standardizing information exchange between countries.
Therapeutics goods administration & Row Countries
The document discusses regulatory requirements for pharmaceutical products in Australia and other countries collectively referred to as the "Rest of the World" or ROW. It outlines the role of the Therapeutic Goods Administration (TGA) in Australia to ensure quality, safety and efficacy of medicines. The TGA approves higher risk medicines and includes lower risk listed medicines in the Australian Register of Therapeutic Goods. Manufacturers must be licensed and comply with Good Manufacturing Practice standards. ROW countries have similar regulatory frameworks with a focus on pre-market assessment, post-market monitoring, and licensing of manufacturers. Requirements for registration in various ROW regions are also summarized.
Assignment avd@ gmp
1) GMP (Good Manufacturing Practice) guidelines are important regulations that help ensure animal vaccines and other drugs/medical products are produced safely and are effective. They cover all aspects of production from materials to equipment to staff training.
2) Key components of GMP include quality management, quality control, sanitation, validation, documentation and more. Strict adherence to GMP helps reduce risks like contamination and errors that could harm patients.
3) For animal vaccines specifically, following GMP is critical given the live organisms involved and safety precautions needed. Facilities must be designed to properly handle biosafety requirements as well as aseptic processing.
Pharmacy “it’s even more than you can imagine.”
It help for students Doctor of Pharmacy (Pharm D), M Pharm -Pharmacy Practice, Bachelor of Pharmacy ,Diploma pharmacy, working pharmacist i.e community, hospital and clinical pharmacist - Scope of pharmacy and skills required to be success in pharmacy practice. It is produced and presented as a part of a part of " SKILL DEVELOPMENT TRAINING PROGRAM-2015" on 17 06 2015 as a part of Technical Session -II sponsored by Tirumala Tirupati Devasthanams Tirupati to the students of Sri Padmavathi Polytechnic Tirupati to bring a Co-Ordination between education and employability potentials in corporate sector.
GMB NEW (2).pptx
cGMP refers to current good manufacturing practices regulations enforced by the US FDA to ensure quality control of pharmaceutical products. cGMP provides minimum requirements for facilities, equipment, personnel, documentation, packaging and labeling. Some key points of cGMP include employing up-to-date technologies to prevent contamination and errors, following written standard operating procedures, conducting self-inspections, and ensuring raw materials, manufacturing processes and finished products meet specifications. Strict adherence to cGMP is important as it helps ensure the safety, efficacy and consistency of pharmaceutical products for patients. Incidents like the thalidomide tragedy and Tylenol tampering case demonstrate why following cGMP is crucial in the pharmaceutical industry.
Excipients presentation-part 1-definition and regulation
This presentation will explain the definition of pharmaceutical excipients. Also, it shows the main regulation institutions and existing regulation. It shows the main roles of pharma excipients as well as the ideal properties of pharma excipients. This first part ends with a short view of the excipient market.
Good Manufacturing Practice (GMP) | Arrelic Insights
Good manufacturing practice (GMP) is that part of quality assurance which ensures that products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by the marketing authorization. GMP is aimed primarily at diminishing the risks inherent in any pharmaceutical production, which may broadly be categorized in two groups: cross contamination/mix-ups and false labeling. Above all, manufacturers must not place patients at risk due to inadequate safety, quality or efficacy; for this reason, risk assessment has come to play an important role in WHO quality assurance guidelines.
Gmp and-cgmp-considerations-1232704699855468-1
GMP and cGMP considerations ensure consistent manufacturing and quality control of pharmaceutical products. Key points:
1. GMP aims to minimize risks like contamination or incorrect dosing that cannot be eliminated through final testing.
2. QA, GMP and QC are interrelated but distinct - QA ensures overall quality, GMP covers all production aspects, and QC involves sampling, testing and release procedures.
3. Following GMP guidelines is important for safety, efficacy and export opportunities. GMP requires documented procedures covering all steps to build quality into every batch.
GMP and cGMP
GMP (good manufacturing practices) and cGMP (current good manufacturing practices) are quality standards for the manufacture of pharmaceutical products and medical devices. They help ensure that products are consistently produced and controlled according to quality standards for safety and efficacy. Key aspects of GMP include establishing processes and procedures for production, cleaning, maintenance, personnel training, and quality testing of products. Following GMP guidelines helps manufacturers produce pharmaceuticals that meet the necessary quality standards.
Nutraceuticals ppt (1)
The Food Safety and Standards Authority of India (FSSAI) regulates the import, manufacture, and sale of nutraceuticals in India under the Food Safety and Standard Act 2006. FSSAI requires licenses for all parties involved in the food sector and has established regulations for product evaluation, analysis, health claims and other aspects of importing, manufacturing and selling nutraceuticals. Licenses include basic registration for small retailers, state licenses for medium businesses, and central licenses for large manufacturers. FSSAI regulations aim to standardize and ensure safety of the nutraceutical industry in India.
Ceuta Pharmacovigilance Presentation 2014
This document provides information on pharmacovigilance and outlines Ceuta Healthcare's responsibilities and procedures for reporting adverse events and product issues. It defines key terms like adverse events, serious adverse events, and medication errors. It describes requirements for reporting pregnancy exposures, overdoses, misuse, lack of efficacy, and other special scenarios. The document explains how to access and provide the latest product information to customers and stakeholders. Ceuta employees are responsible for notifying the marketing authorization holder of any adverse events or quality complaints.
CDSCO.pptx
The document provides information on the Central Drug Standard Control Organization (CDSCO), which is India's main drug regulatory authority. It describes CDSCO's vision, mission, and organizational structure. CDSCO regulates pharmaceuticals, medical devices, and clinical trials in India. It is responsible for drug approval and ensures drugs meet standards of safety, efficacy, and quality. CDSCO oversees various offices across India and has laboratories for drug testing.
Pharma Uptoday : Volume 2 issue may 2014
The document summarizes key changes in proposed new EU regulations for clinical trials:
- The new regulations aim to streamline and harmonize rules across EU states to make multinational clinical trials less costly and bureaucratic.
- Currently, regulations are criticized for disproportionately high costs and lack of harmonization that have reduced EU clinical trials by 25%.
- Key changes in the new regulations are aimed at restoring EU competitiveness in clinical research and development of new treatments.
Pharmaceutical Industry - Business Perspectives for IT Teams
The document provides an overview of the pharmaceutical industry and drug development process. It discusses how the industry is highly regulated and the various stages of drug development from target discovery through clinical trials and regulatory approval. It also outlines the major areas of pharmaceutical manufacturing including biochemical and chemical API production, bulk manufacturing, and packaging. Regulatory compliance and good manufacturing practices are essential throughout the manufacturing process.
Strategy for enhanced marketing authorization final docx
This document outlines strategies for enhancing marketing authorization of medicines in Ethiopia. It discusses categorizing products as high or low risk and taking a risk-based approach to evaluation and inspection. For low risk products, less stringent evaluation is proposed. External assessors are suggested to help address staffing challenges. The strategies aim to efficiently use limited resources to protect public health.
Pharma & Medical Devices Industry Research & Analysis | Aranca
Aranca supports several global pharmaceutical and medical device companies with business research & market intelligence on new products & markets, competitor activities, regulatory environment, innovation trends, product pipelines and supply chain efficiency
Veterinary pharmacy
The document provides an overview of veterinary pharmacy in the UK, including relevant legislation, regulatory bodies, classification of veterinary medicines, prescribing and dispensing requirements, record keeping, adverse reaction reporting, and educational opportunities. Key points covered include the Veterinary Medicines Regulations, roles of the VMD and other committees, the medicine classification system, cascade protocols for authorized and unauthorized medicines, withdrawal periods, and requirements for prescriptions, labels, and record keeping.
Audit of vendors and Production department
Detailed about the Production Department and Vendor Audit Which is use as in Pharmaceutical Industries.
Labeling in pharmaceutical packaging
This presentation contains legal requirements for labeling for pharmaceuticals, types of label, objective of label and recent advancement in labeling of pharmaceuticals.
3..Post marketing surveillance.pptx
This document discusses post marketing surveillance of drugs. It defines post marketing surveillance as monitoring drugs once they reach the market to evaluate their safety and efficacy in wider patient populations than clinical trials. Several methods of post marketing surveillance are described, including spontaneous reporting, cohort studies, and case control studies. The goals of post marketing surveillance include identifying unexpected side effects, assessing drug interactions, and ensuring safe use of medications. It is an important part of pharmacovigilance, the science of monitoring pharmaceutical safety and outcomes.
Assignment by harvindar from prashant sir
The document discusses current Good Manufacturing Practices (cGMP) regulations for drug manufacturing. It states that cGMP regulations are established by the FDA to ensure drug products are safe, effective and meet quality standards. The FDA approves new drug applications and inspects facilities to ensure compliance with cGMP regulations. Manufacturers must follow strict controls and quality standards for facilities, equipment, materials, labeling, packaging, and expiration dating under cGMP.
WHAT IS GMP CERTIFICATION?
GMP stands for Good Manufacturing Practices and is a list of guidelines for procedures, procedures, and documentation that assures that the label on the product accurately represents the actual components of the product.
For more detail Visit these sites.
Which are the Best Indian Nutraceutical Manufacturing Companies for Venezuela
If your pharma business operates in Venezuela's nutraceutical supplement market, JoinHub Pharma is your one-stop solution for all your needs.
Career Talk
Institution's Innovation Council (IIC) of Noida Institute of Engineering and Technology (Pharmacy Institute) organized a webinar on "Career Talk: How to ace summer internship?" keynote lecture was delivered by Abhijit Debnath, Asst. Professor NIET (Pharmacy Institute).
2 - Dashboard (Clarifications & Updates)
This document provides a summary of a dashboard and reflective review presentation from 2019. It discusses various quality topics related to pharmaceutical manufacturing including assay testing of APIs, use of preservatives, microbial limits, process validation, cleaning validation, API testing responsibilities, and more. Key points emphasized include using a risk-based approach to assessing changes and product holds, ensuring sampling methods are scientifically sound, and the importance of evaluating cleaning procedures to maintain ability to clean. Recent regulatory guidance from EMA regarding evaluation of nitrosamines is also summarized.
More Related Content
Similar to Linked in Auditing Post-July16
Excipients presentation-part 1-definition and regulation
This presentation will explain the definition of pharmaceutical excipients. Also, it shows the main regulation institutions and existing regulation. It shows the main roles of pharma excipients as well as the ideal properties of pharma excipients. This first part ends with a short view of the excipient market.
Good Manufacturing Practice (GMP) | Arrelic Insights
Good manufacturing practice (GMP) is that part of quality assurance which ensures that products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by the marketing authorization. GMP is aimed primarily at diminishing the risks inherent in any pharmaceutical production, which may broadly be categorized in two groups: cross contamination/mix-ups and false labeling. Above all, manufacturers must not place patients at risk due to inadequate safety, quality or efficacy; for this reason, risk assessment has come to play an important role in WHO quality assurance guidelines.
Gmp and-cgmp-considerations-1232704699855468-1
GMP and cGMP considerations ensure consistent manufacturing and quality control of pharmaceutical products. Key points:
1. GMP aims to minimize risks like contamination or incorrect dosing that cannot be eliminated through final testing.
2. QA, GMP and QC are interrelated but distinct - QA ensures overall quality, GMP covers all production aspects, and QC involves sampling, testing and release procedures.
3. Following GMP guidelines is important for safety, efficacy and export opportunities. GMP requires documented procedures covering all steps to build quality into every batch.
GMP and cGMP
GMP (good manufacturing practices) and cGMP (current good manufacturing practices) are quality standards for the manufacture of pharmaceutical products and medical devices. They help ensure that products are consistently produced and controlled according to quality standards for safety and efficacy. Key aspects of GMP include establishing processes and procedures for production, cleaning, maintenance, personnel training, and quality testing of products. Following GMP guidelines helps manufacturers produce pharmaceuticals that meet the necessary quality standards.
Nutraceuticals ppt (1)
The Food Safety and Standards Authority of India (FSSAI) regulates the import, manufacture, and sale of nutraceuticals in India under the Food Safety and Standard Act 2006. FSSAI requires licenses for all parties involved in the food sector and has established regulations for product evaluation, analysis, health claims and other aspects of importing, manufacturing and selling nutraceuticals. Licenses include basic registration for small retailers, state licenses for medium businesses, and central licenses for large manufacturers. FSSAI regulations aim to standardize and ensure safety of the nutraceutical industry in India.
Ceuta Pharmacovigilance Presentation 2014
This document provides information on pharmacovigilance and outlines Ceuta Healthcare's responsibilities and procedures for reporting adverse events and product issues. It defines key terms like adverse events, serious adverse events, and medication errors. It describes requirements for reporting pregnancy exposures, overdoses, misuse, lack of efficacy, and other special scenarios. The document explains how to access and provide the latest product information to customers and stakeholders. Ceuta employees are responsible for notifying the marketing authorization holder of any adverse events or quality complaints.
CDSCO.pptx
The document provides information on the Central Drug Standard Control Organization (CDSCO), which is India's main drug regulatory authority. It describes CDSCO's vision, mission, and organizational structure. CDSCO regulates pharmaceuticals, medical devices, and clinical trials in India. It is responsible for drug approval and ensures drugs meet standards of safety, efficacy, and quality. CDSCO oversees various offices across India and has laboratories for drug testing.
Pharma Uptoday : Volume 2 issue may 2014
The document summarizes key changes in proposed new EU regulations for clinical trials:
- The new regulations aim to streamline and harmonize rules across EU states to make multinational clinical trials less costly and bureaucratic.
- Currently, regulations are criticized for disproportionately high costs and lack of harmonization that have reduced EU clinical trials by 25%.
- Key changes in the new regulations are aimed at restoring EU competitiveness in clinical research and development of new treatments.
Pharmaceutical Industry - Business Perspectives for IT Teams
The document provides an overview of the pharmaceutical industry and drug development process. It discusses how the industry is highly regulated and the various stages of drug development from target discovery through clinical trials and regulatory approval. It also outlines the major areas of pharmaceutical manufacturing including biochemical and chemical API production, bulk manufacturing, and packaging. Regulatory compliance and good manufacturing practices are essential throughout the manufacturing process.
Strategy for enhanced marketing authorization final docx
This document outlines strategies for enhancing marketing authorization of medicines in Ethiopia. It discusses categorizing products as high or low risk and taking a risk-based approach to evaluation and inspection. For low risk products, less stringent evaluation is proposed. External assessors are suggested to help address staffing challenges. The strategies aim to efficiently use limited resources to protect public health.
Pharma & Medical Devices Industry Research & Analysis | Aranca
Aranca supports several global pharmaceutical and medical device companies with business research & market intelligence on new products & markets, competitor activities, regulatory environment, innovation trends, product pipelines and supply chain efficiency
Veterinary pharmacy
The document provides an overview of veterinary pharmacy in the UK, including relevant legislation, regulatory bodies, classification of veterinary medicines, prescribing and dispensing requirements, record keeping, adverse reaction reporting, and educational opportunities. Key points covered include the Veterinary Medicines Regulations, roles of the VMD and other committees, the medicine classification system, cascade protocols for authorized and unauthorized medicines, withdrawal periods, and requirements for prescriptions, labels, and record keeping.
Audit of vendors and Production department
Detailed about the Production Department and Vendor Audit Which is use as in Pharmaceutical Industries.
Labeling in pharmaceutical packaging
This presentation contains legal requirements for labeling for pharmaceuticals, types of label, objective of label and recent advancement in labeling of pharmaceuticals.
3..Post marketing surveillance.pptx
This document discusses post marketing surveillance of drugs. It defines post marketing surveillance as monitoring drugs once they reach the market to evaluate their safety and efficacy in wider patient populations than clinical trials. Several methods of post marketing surveillance are described, including spontaneous reporting, cohort studies, and case control studies. The goals of post marketing surveillance include identifying unexpected side effects, assessing drug interactions, and ensuring safe use of medications. It is an important part of pharmacovigilance, the science of monitoring pharmaceutical safety and outcomes.
Assignment by harvindar from prashant sir
The document discusses current Good Manufacturing Practices (cGMP) regulations for drug manufacturing. It states that cGMP regulations are established by the FDA to ensure drug products are safe, effective and meet quality standards. The FDA approves new drug applications and inspects facilities to ensure compliance with cGMP regulations. Manufacturers must follow strict controls and quality standards for facilities, equipment, materials, labeling, packaging, and expiration dating under cGMP.
WHAT IS GMP CERTIFICATION?
GMP stands for Good Manufacturing Practices and is a list of guidelines for procedures, procedures, and documentation that assures that the label on the product accurately represents the actual components of the product.
For more detail Visit these sites.
Which are the Best Indian Nutraceutical Manufacturing Companies for Venezuela
If your pharma business operates in Venezuela's nutraceutical supplement market, JoinHub Pharma is your one-stop solution for all your needs.
Career Talk
Institution's Innovation Council (IIC) of Noida Institute of Engineering and Technology (Pharmacy Institute) organized a webinar on "Career Talk: How to ace summer internship?" keynote lecture was delivered by Abhijit Debnath, Asst. Professor NIET (Pharmacy Institute).
2 - Dashboard (Clarifications & Updates)
This document provides a summary of a dashboard and reflective review presentation from 2019. It discusses various quality topics related to pharmaceutical manufacturing including assay testing of APIs, use of preservatives, microbial limits, process validation, cleaning validation, API testing responsibilities, and more. Key points emphasized include using a risk-based approach to assessing changes and product holds, ensuring sampling methods are scientifically sound, and the importance of evaluating cleaning procedures to maintain ability to clean. Recent regulatory guidance from EMA regarding evaluation of nitrosamines is also summarized.
Similar to Linked in Auditing Post-July16 (20)
Excipients presentation-part 1-definition and regulation
Excipients presentation-part 1-definition and regulation
Good Manufacturing Practice (GMP) | Arrelic Insights
Good Manufacturing Practice (GMP) | Arrelic Insights
Pharmaceutical Industry - Business Perspectives for IT Teams
Pharmaceutical Industry - Business Perspectives for IT Teams
Strategy for enhanced marketing authorization final docx
Strategy for enhanced marketing authorization final docx
Pharma & Medical Devices Industry Research & Analysis | Aranca
Pharma & Medical Devices Industry Research & Analysis | Aranca
Which are the Best Indian Nutraceutical Manufacturing Companies for Venezuela
Which are the Best Indian Nutraceutical Manufacturing Companies for Venezuela
Linked in Auditing Post-July16
- 1. I am alwaysinterestedinfinding more auditingworkinAustraliaandAsia. Whywould someone use me as a GMPauditor ?. The main reasonwouldbe due tomy experience. I have beenworkingin the pharmaceutical industryfor43 years I have beena consultanttopharmaceutical andveterinarymanufacturersfor27 years I have beenanapprovedAPVMA auditorfor20 years(auditingmanufacturersof veterinary medicines) Many of youwill notknowme personallybutwill have readmyNewsletter(The PHARMSCIENCE Newsletter).Istartedsharingmythoughtsandexperience inthe PHARMSCIENCENewsletterin1990 (26 yearsago). The PHARMSCIENCENewsletternow hasreadersthroughoutAustralasia. What type of facilitieshave I audited ?. Pharmaceutical manufacturers–all dose forms(PICSbased) Manufacturersof veterinarymedicines(APVMA GMP Code) Printersof labels,cartonsandleaflets Cleanroomgarmentlaundries Manufacturersof Active Pharmaceutical Ingredients(PICS/ICHQ7A based) Contract sterilisationfacilities Contract testinglaboratories Cosmeticmanufacturers (ISO22716) Auditingworkcouldbe done oncontract basisor as a consultant. If you may be interestedpleaseringme on0411-439852. A preliminarymeetingwill costyounothing.